Harmancey Romain, Wilson Christopher R, Taegtmeyer Heinrich
Department of Internal Medicine, Division of Cardiology, University of Texas Medical School at Houston, 6431 Fannin, MSB 1.246, Houston, TX 77030, USA.
Hypertension. 2008 Aug;52(2):181-7. doi: 10.1161/HYPERTENSIONAHA.108.110031. Epub 2008 Jun 23.
Obesity affects the cardiovascular system at many different levels, including the heart muscle itself. Clinical and experimental studies have shown an accumulation of triglycerides and other lipid species in cardiomyocytes. Analogous to hepatic steatosis, investigators have introduced the term “cardiac steatosis”. The present review addresses the complex relationships between cardiac fuel homeostasis, insulin resistance, and proposed mechanisms of damage to cardiomyocytes in different models of obesity, insulin resistance, and lipotoxicity. Specifically, the review weighs the evidence whether there is a heart muscle disorder in human obesity. It discusses how adipokines can modulate cardiac metabolism, and it focuses on the metabolic remodeling accompanying increased fatty acid supply in the heart of rodent models of lipotoxicity, with special attention to the role played by mitochondrial uncoupling and futile cycling. We stress the notion that, in spite of the many proposed mechanisms, cardiac lipotoxicity is still a hypothesis rather than an established pathophysiologic principle. Although the concept of a “lipotoxic cardiomyopathy” seems attractive, we propose instead a series of steps on a path from adaptation to maladaptation of the heart in obesity. A case in point is insulin resistance of the heart which may be both adaptive (protecting the heart from excess fuel) or maladaptive (associated with reactive oxygen species formation and activation of signaling pathways of programmed cell death). The present literature reflects an extraordinary complexity of the heart’s metabolic, functional and structural changes in obesity.
肥胖在许多不同层面影响心血管系统,包括心肌本身。临床和实验研究表明心肌细胞内甘油三酯及其他脂质种类会蓄积。与肝脂肪变性类似,研究人员引入了“心脏脂肪变性”这一术语。本综述阐述了在肥胖、胰岛素抵抗和脂毒性等不同模型中,心脏能量稳态、胰岛素抵抗与心肌细胞损伤的潜在机制之间的复杂关系。具体而言,该综述权衡了人类肥胖中是否存在心肌疾病的证据。它讨论了脂肪因子如何调节心脏代谢,并聚焦于脂毒性啮齿动物模型心脏中脂肪酸供应增加时伴随的代谢重塑,特别关注线粒体解偶联和无效循环所起的作用。我们强调,尽管提出了许多机制,但心脏脂毒性仍然只是一种假说,而非既定的病理生理原则。虽然“脂毒性心肌病”的概念似乎很有吸引力,但我们提出了肥胖状态下心脏从适应到适应不良过程中的一系列步骤。一个典型例子是心脏的胰岛素抵抗,它可能具有适应性(保护心脏免受过多能量的影响)或适应不良性(与活性氧的形成以及程序性细胞死亡信号通路的激活有关)。当前文献反映了肥胖状态下心脏代谢、功能和结构变化的异常复杂性。